Company intelligence / Profile preview
Forge Biologics
- Ownership
- Private
- Employees
- ~201
- Development stage
- Other
Overview
Forge Biologics operates one of the largest dedicated AAV gene therapy manufacturing facilities in the US ("the Hearth"), providing end-to-end services from process development through cGMP/commercial production. The company’s FUEL™ platform offers significant productivity gains over industry standards. More than 50 developers have used their technologies across over 500 manufactured batches supporting more than 35 disease indications. As a hybrid CDMO/therapeutic developer, it also maintains an undisclosed proprietary pipeline of novel AAV-based gene therapies.
- Therapeutic areas
- OtherOphthalmology
- Modalities
- Gene therapy (AAV-based)viral vectorsplasmid DNA manufacturing
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Forge Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Forge Biologics.